Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
20.0%
% of XLV's 60 holdings also in PJP
40.0%
% of PJP's 30 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.7% | 5.3% | 5.3% |
|
ELI LILLY & CO | 13.4% | 5.3% | 5.3% |
|
ABBVIE INC | 6.2% | 4.8% | 4.8% |
|
ABBOTT LABORATORIES | 4.6% | 5.4% | 4.6% |
|
MERCK & CO. INC. | 4.0% | 4.8% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 8.5% |
|
ELI LILLY & CO | 8.2% |
|
INTUITIVE SURGICAL INC | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
DANAHER CORP | 2.4% |
|
STRYKER CORP | 2.4% |
|
JOHNSON & JOHNSON | 2.3% |
 |
MEDTRONIC PLC | 2.1% |
XLV Underweight Relative to PJP
|
BIOSANTE PHARMACEUTICALS INC | -3.9% |
|
TARSUS PHARMACEUTICALS, INC. | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.1% |
|
INNOVIVA, INC. | -3.1% |
|
PERRIGO CO | -3.1% |
|
PACIRA PHARMACEUTICALS INC | -3.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |